CSF1R and early-onset autosomal dominant Alzheimer disease: Prolonged or sustained depletion of microglia with the CSF1R inhibitors has been shown to confer neuroprotection and improve cognitive recovery in experimental models of neurological disorders including acute hippocampal lesion, Alzheimer's disease, and multiple sclerosis 38, 39, 42, 83, 84.